Completed PHASE4 INTERVENTIONAL 2-arm NCT00553293

Nordic Luveris Study

Recombinant LH Supplementation to Recombinant FSH During the Final Days of Controlled Ovarian Stimulation for IVF: a Multicentre, Prospective, Randomized, Controlled Trial

Sponsor: Helse Fonna

Conditions In Vitro Fertilization Infertility

Interventions recombinant follicle stimulating hormone (Gonal-f) recombinant luteinizing hormone (Luveris)

Updated 4 times since 2017 Last updated: Nov 2, 2007 Started: Aug 31, 2003 Completion: Nov 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates In Vitro Fertilization and Infertility and is currently completed. Helse Fonna leads this study, which shows 4 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Helse Fonna
Herlev Hospital
Holbaek Sygehus
Hvidovre University Hospital
Karolinska University Hospital
Odense University Hospital
Regionshospitalet Viborg, Skive
Rigshospitalet, Denmark
Turku Hospital

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark